Clinical Trial

Roche’s New Therapy Prolongs Life of Melanoma Patients

Roche’s New Therapy Prolongs Life of Melanoma Patients

New Therapy Prolongs Life of Melanoma Patients Roche has announced promising results for their Phase 3 clinical study (the BRIM3 trial) of the targeted anticancer drug PLX4032 in patients with previously untreated melanoma that has spread throughout the body.

Trial News: Ketamine Drug Shows Great Promise in Treating Depression

Trial News: Ketamine Drug Shows Great Promise in Treating Depression

Some people with depression do not respond enough, or at all, to standard anti-depression drugs. For these people the recent development of treatments based on the drug ketamine have shown great promise. After a series of clinical trials, the pharmaceutical giant Johnson & Johnson is seeking government approval...

Qnexa – Combination Weight-Loss Drug Meet Challenges to FDA Approval

 Qnexa – Combination Weight-Loss Drug Meet Challenges to FDA Approval

Vivus Inc has released promising results for their Phase 3 clinical trial CONQUER which was designed to evaluate the safety and efficacy of their new investigational weight loss drug Qnexa. Despite Qnexa’s promising results, the FDA is fearful of unpredictable and dangerous side effects and has been hesitant to approve many weight loss products, including Qnexa...

[12 3 4 5  >>